Non-alcoholic steatohepatitis and cancer

Area of Science:

• Hepatology
• Oncology
• Metabolic Diseases

Background:

• Non-alcoholic steatohepatitis (NASH) is a progressive liver disease that can lead to cirrhosis.
• Hepatocellular carcinoma (HCC) is a known complication in the natural history of NASH-related cirrhosis.
• Cryptogenic cirrhosis also shows a significant association with HCC development.

Purpose of the Study:

• To highlight the link between NASH and HCC.
• To underscore the growing incidence of NASH-related HCC due to metabolic disease epidemics.
• To emphasize the need for preventative measures against non-alcoholic fatty liver disease.

Main Methods:

• Literature review and synthesis of existing data on NASH, cirrhosis, and HCC.
• Analysis of risk factors including obesity and diabetes.
• Epidemiological trend assessment of NASH-related cancers.

Main Results:

• NASH-related cirrhosis substantially increases the risk of early HCC development.
• HCC diagnosis in NASH patients often occurs late, with large, multifocal tumors.
• Obesity and diabetes are significant risk factors for HCC and other cancers.

Conclusions:

• The increasing prevalence of obesity and diabetes is expected to drive a rise in NASH-related HCC.
• Early diagnosis and intervention are crucial, but prevention of underlying fatty liver disease is paramount.
• Developing new diagnostic tools and therapies should be complemented by efforts to prevent non-alcoholic fatty liver disease.